Key result
Disruption of 14-3-3tau impairs post-MI survival in mice, rescued by p38 MAPK inhibition.
Answers are grounded in this paper and cite their sources.
14-3-3 family members are intracellular dimeric phosphoserine-binding proteins that regulate signal transduction, cell cycle, apoptotic, and metabolic cascades. Previous work with global 14-3-3 protein inhibitors suggested that these proteins play a critical role in antagonizing apoptotic cell death in response to provocative stimuli. To determine the specific role of one family member in apoptosis, mice were generated with targeted disruption of the 14-3-3tau gene. 14-3-3tau(-/-) mice did not survive embryonic development, but haploinsufficient mice appeared normal at birth and were fertile. Cultured adult cardiomyocytes derived from 14-3-3tau(+/-) mice were sensitized to apoptosis in response to hydrogen peroxide or UV irradiation. 14-3-3tau(+/-) mice were intolerant of experimental myocardial infarction and developed pathological ventricular remodeling with increased cardiomyocyte apoptosis. ASK1, c-jun NH(2)-terminal kinase, and p38 mitogen-activated protein kinase (MAPK) activation was increased, but extracellular signal-regulated kinase MAPK activation was reduced, in 14-3-3tau(+/-) cardiac tissue. Inhibition of p38 MAPK increased survival in 14-3-3tau(+/-) mice subjected to myocardial infarction. These results demonstrate that 14-3-3tau plays a critical antiapoptotic function in cardiomyocytes and that therapeutic agents that increase 14-3-3tau activity may be beneficial to patients with myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2006) studied Experimental myocardial infarction and cardiomyocyte apoptosis. Targeted disruption of the 14-3-3tau gene and p38 MAPK inhibition vs. Wild-type controls was evaluated on Cardiomyocyte apoptosis, pathological ventricular remodeling, and survival after experimental myocardial infarction. Targeted disruption of 14-3-3tau sensitized murine cardiomyocytes to apoptosis and impaired survival post-myocardial infarction, which was improved by p38 MAPK inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: